stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Korsana Biosciences, Inc. Common StockKRSA
$31.032.91%-0.93

Korsana Biosciences, Inc. Common Stock (KRSA)

Date: 2026-11-04 16:00O: 31.86H: 33.44L: 29.80C: 30.39Vol: 89.48k
Schlusskurs vom Vortag:
$31.96
Offen:
$31.86
24-Stunden-Volumen:
33,633
Relatives Volumen:
0.19
Marktkapitalisierung:
$1.41B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.06%
1M Leistung:
+1.77%
6M Leistung:
0.00%
1Y Leistung:
0.00%
1-Tages-Spanne:
$30.71$33.44
1-Wochen-Bereich:
$29.29$33.23
52-Wochen-Spanne:
$21.00$37.27

Korsana Biosciences, Inc. Common Stock Aktie (KRSA) Unternehmensprofil

Firmenname
Korsana Biosciences, Inc. Common Stock
Telefon
-
Adresse
USA
Mitarbeiter
1
X
-
Nächster Verdiensttermin
2026-11-11
Neueste SEC-Einreichungen
SEC
KRSA-Diskussionen auf X
X

 

Marktkapitalisierung

 

Umsatz

 

Nettogewinn

 

Free Cashflow

 

ENV

 

Korsana Biosciences, Inc. Common Stock Aktie (KRSA) Hochstufungen & Herabstufungen

DatumAktionAnalytikerRatingänderung
2026-10-05EingeleitetWedbushOutperform
2026-09-28EingeleitetGuggenheimBuy
2026-09-14EingeleitetStifelBuy
2026-09-14EingeleitetTD CowenBuy

Finanzdaten der Korsana Biosciences, Inc. Common Stock-Aktie (KRSA)

ZeitraumTrendFY 2025FY 2024FY 2023FY 2022FY 2021
Enddatum des Zeitraums2025-12-312024-12-312022-12-312022-12-312021-12-31
Revenue USD (M)2.070.000.001.633.94
Research and development USD (M)0.961.521.5231.4937.64
Operating expenses USD (M)7.0512.9512.9546.0059.14
Operating income USD (M)-4.97-12.95-12.95-44.37-55.20
Income before tax USD (M)-3.53-5.26-5.26-44.08-51.65
Income tax expense USD (M)0.000.000.000.000.00
Net income USD (M)-3.53-5.26-5.26-44.08-51.65
Basic EPS USD/shares-1.11-2.25-2.25-1.01-
Diluted EPS USD/shares-1.11-2.25-2.25-1.01-
Basic weighted shares shares (M)3.182.342.3443.47-
Diluted weighted shares shares (M)3.182.342.3443.47-

Korsana Biosciences, Inc. Common Stock-Aktie (KRSA) Insiderhandel

  • MICHAEL HIGGINSOct 22 '26
    Director
    Transaktion
    Proposed Sale
    Kosten
    $32.00
    #Aktien
    1,107
    Wert ($)
    35,424
    #Aktien Gesamt
    0
  • Director
    Transaktion
    Proposed Sale
    Kosten
    $34.99
    #Aktien
    4,903
    Wert ($)
    171,556
    #Aktien Gesamt
    0
  • Director
    Transaktion
    Proposed Sale
    Kosten
    $34.99
    #Aktien
    100
    Wert ($)
    3,499
    #Aktien Gesamt
    0
  • Director
    Transaktion
    Proposed Sale
    Kosten
    $34.99
    #Aktien
    2,139
    Wert ($)
    74,844
    #Aktien Gesamt
    0
  • Chief Financial Officer
    Transaktion
    Option Exercise
    Kosten
    $2.35
    #Aktien
    25,000
    Wert ($)
    58,875
    #Aktien Gesamt
    25,018
  • See Remarks
    Transaktion
    Option Exercise
    Kosten
    $3.30
    #Aktien
    55,849
    Wert ($)
    184,302
    #Aktien Gesamt
    156,152
InsiderhandelBeziehungDatumTransaktionKosten#AktienWert ($)#Aktien Gesamt
MICHAEL HIGGINSDirectorOct 22 '26Proposed Sale$32.001,10735,4240
ERROL B DE SOUZADirectorSep 23 '26Proposed Sale$34.994,903171,5560
ERROL B DE SOUZADirectorSep 22 '26Proposed Sale$34.991003,4990
ERROL B DE SOUZADirectorSep 18 '26Proposed Sale$34.992,13974,8440
CHICKO RHONDA M.Chief Financial OfficerAug 14 '26Option Exercise$2.3525,00058,87525,018
Graul Regina MargaretSee RemarksAug 14 '26Option Exercise$3.3055,849184,302156,152

Korsana Biosciences, Inc. Common Stock Aktie (KRSA) Neueste Nachrichten

Oct 30, 2026
Oct 30, 2026
Oct 27, 2026
Oct 27, 2026
Oct 22, 2026
Oct 22, 2026
Oct 22, 2026
Oct 22, 2026
Oct 22, 2026
Oct 22, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 07, 2026
Oct 07, 2026
Oct 05, 2026
Oct 05, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 20, 2026
Sep 20, 2026
Sep 18, 2026
Sep 18, 2026
Sep 18, 2026
Sep 18, 2026
Sep 16, 2026
Sep 16, 2026
Sep 15, 2026
Sep 15, 2026
Sep 13, 2026
Sep 13, 2026
Sep 13, 2026
Sep 13, 2026
Sep 12, 2026
Sep 12, 2026
Sep 11, 2026
Sep 11, 2026
Sep 11, 2026
Sep 11, 2026
Sep 11, 2026
Sep 11, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Aug 03, 2026
Aug 03, 2026
Aug 03, 2026
Aug 03, 2026
Apr 20, 2026
Apr 20, 2026
Apr 03, 2026
Apr 03, 2026
Apr 02, 2026
Apr 02, 2026
Apr 02, 2026
Apr 02, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 01, 2026
Apr 24, 2025
Apr 24, 2025
Sep 14, 2021
Sep 14, 2021
Feb 12, 2021
Feb 12, 2021
Aug 20, 2020
Aug 20, 2020

Ähnlich wie KRSA